Terminology Service < Semantic Lookup Platform

All terms in EFO

Label	Id	Description
Plasma Cell Count	EFO_0009248	[The determination of the amount of plasma cells present in a sample. [ NCI ]]
viral subtype carrier status	EFO_0010234	[Quantification of the presence or absence of a particular viral subtype in an individual.]
Precursor Plasma Cell Count	EFO_0009249	[The determination of the number of precursor plasma cells present in a sample. [ NCI ]]
response to proton-pump inhibitor	EFO_0010235	[Any process that results in a change in state or activity of a cell or an organism as a result of a proton-pump inhibitor stimulus. Proton-pump inhibitors are a group of medications whose main action is a pronounced and long-lasting reduction of stomach acid production.]
response to drug	GO_0042493	[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.]
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor	CHEBI_49200	[An EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that inhibits H(+)/K(+)-exchanging ATPase, EC 3.6.3.10. Such compounds are also known as proton pump inhibitors.]
Myeloid to Erythroid Ratio Measurement	EFO_0009243	[The determination of the ratio of myeloid cells compared to erythroid cells present in a sample. The measurement may be expressed as a ratio or percentage. [ NCI ]]
osteocalcin measurement	EFO_0010232	[Quantification of the amount of osteocalcin in a sample]
osteoblast	CL_0000062	[Skeletogenic cell that secretes osteoid, is capable of producing mineralized (hydroxyapatite) matrix, is located adjacent to or within osteoid tissue, and arises from the transformation of a preosteoblast cell.]
genotoxic compound exposure measurement	EFO_0010233	[Quantification of some aspect of exposure to genotoxic compounds, i.e. compounds that may cause DNA damage.]
cancer	EFO_0000311	[A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.]
chromosomal aberration	EFO_0000336	[An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.]
Neutrophilic Metamyelocyte Count	EFO_0009244	[The determination of the number of neutrophilic metamyelocytes in a blood sample. [ NCI ]]
Neutrophilic Myelocyte Count	EFO_0009245	[The determination of the number of neutrophilic myelocytes in a blood sample. [ NCI ]]
phosphatidylinositol measurement	EFO_0010230	[A quantification of phosphatidylinositols.]
phosphatidylinositol	CHEBI_28874	[Any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol.]
Neutrophils Band Form to Neutrophils Ratio Measurement	EFO_0009246	[The determination of the ratio of neutrophil band form compared to neutrophils present in a sample. The measurement may be expressed as a ratio or percentage. [ NCI]]
sterol measurement	EFO_0010231	[A quantification of sterols.]
sterol	CHEBI_15889	[Any 3-hydroxy steroid whose skeleton is closely related to cholestan-3-ol (additional carbon atoms may be present in the side chain).]
1,4-dithiothreitol	CHEBI_18320	[The threo-diastereomer of 1,4-dimercaptobutane-2,3-diol.]